These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2166209

  • 1. [Low molecular weight heparins].
    Agnelli G, Cosmi B.
    Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with low molecular weight heparins.
    Nenci GG, Agnelli G.
    Thromb Res Suppl; 1990; 11():69-87. PubMed ID: 2177577
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN, Wille-Jørgensen PA, Hauch O.
    Ugeskr Laeger; 1994 Sep 26; 156(39):5667-72. PubMed ID: 7985248
    [Abstract] [Full Text] [Related]

  • 4. Successors to heparin: new antithrombotic agents.
    Turpie AG.
    Am Heart J; 1997 Nov 26; 134(5 Pt 2):S71-7. PubMed ID: 9396637
    [Abstract] [Full Text] [Related]

  • 5. [Low molecular weight heparin].
    Pini M.
    Recenti Prog Med; 1997 Dec 26; 88(12):594-602. PubMed ID: 9522605
    [Abstract] [Full Text] [Related]

  • 6. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D.
    J Fam Pract; 1998 Sep 26; 47(3):185-92. PubMed ID: 9752370
    [Abstract] [Full Text] [Related]

  • 7. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb 26; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 8. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
    Caen JP.
    Thromb Haemost; 1988 Apr 08; 59(2):216-20. PubMed ID: 2838923
    [Abstract] [Full Text] [Related]

  • 9. Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.
    Hirsh J.
    Aust N Z J Med; 1992 Oct 08; 22(5):487-95. PubMed ID: 1280097
    [Abstract] [Full Text] [Related]

  • 10. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis].
    Daures JP, Schved JF, Momas I, Gril JC, Azoulay P, Gremy F.
    Rev Epidemiol Sante Publique; 1989 Oct 08; 37(4):363-9. PubMed ID: 2558404
    [Abstract] [Full Text] [Related]

  • 11. Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery.
    Agnelli G, Sonaglia F.
    Semin Thromb Hemost; 1997 Oct 08; 23(2):143-8. PubMed ID: 9200338
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
    Moreno Gonzalez E, Fontcuberta J, de la Llama F.
    Hepatogastroenterology; 1996 Oct 08; 43(9):744-7. PubMed ID: 8799424
    [Abstract] [Full Text] [Related]

  • 13. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF, Hull RD.
    Clin Chest Med; 1995 Jun 08; 16(2):281-94. PubMed ID: 7656540
    [Abstract] [Full Text] [Related]

  • 14. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 15. An overview of clinical trials of low molecular weight heparin fractions.
    Levine MN, Hirsh J.
    Acta Chir Scand Suppl; 1988 Apr 30; 543():73-9. PubMed ID: 2847461
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of Clivarin and other LMWHs in general surgery: a meta-analysis.
    Kakkar VV.
    Blood Coagul Fibrinolysis; 1993 Dec 30; 4 Suppl 1():S23-7; discussion S29-31. PubMed ID: 8180326
    [Abstract] [Full Text] [Related]

  • 17. Applying risk assessment models in orthopaedic surgery: overview of our clinical experience.
    Gallus AS.
    Blood Coagul Fibrinolysis; 1999 Aug 30; 10 Suppl 2():S53-61. PubMed ID: 10493231
    [Abstract] [Full Text] [Related]

  • 18. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group.
    Pezzuoli G, Neri Serneri GG, Settembrini P, Coggi G, Olivari N, Buzzetti G, Chierichetti S, Scotti A, Scatigna M, Carnovali M.
    Int Surg; 1989 Aug 30; 74(4):205-10. PubMed ID: 2560470
    [Abstract] [Full Text] [Related]

  • 19. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J, Crowther M.
    Thromb Haemost; 1997 Jul 30; 78(1):689-92. PubMed ID: 9198240
    [Abstract] [Full Text] [Related]

  • 20. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U.
    Semin Thromb Hemost; 1990 Oct 30; 16 Suppl():25-33. PubMed ID: 1962901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.